
Julie Lang
Professor · University of Kentucky College of Medicine
Credentials: · · · · · · · ·
History
Research
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
New England Journal of Medicine · 2016 · 452 citations
Adaptive Randomization of Neratinib in Early Breast Cancer
New England Journal of Medicine · 2016 · 292 citations
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Molecular Therapy · 2020 · 192 citations

20 papers

12 papers · 4 as a resident

10 papers
- RV
10 papers · 1 as a resident

10 papers

10 papers

10 papers

9 papers
Clinical trials
- 2018–2020
Study of Topical SOR007 Ointment for Cutaneous Metastases
Principal investigator · Completed · Phase 1, Phase 2
NanOlogy, LLC
- 2013–2027
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Site PI · Recruiting
University of Southern California
- 2010–2031
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Site PI · Recruiting · Phase 2
QuantumLeap Healthcare Collaborative
- 2018–2036





